Biosense Webster, Inc. Showcases Cutting Edge Innovation and Leadership in AF Ablation at HRS Annual Scientific Sessions 2013

Published: May 08, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, will showcase its portfolio of cutting edge innovative technologies and its unrivaled leadership in atrial fibrillation ablation at the 2013 Heart Rhythm Society’s 34th Annual Scientific Sessions in Denver. This meeting draws experts in cardiac rhythm management from around the globe to explore the therapeutics and technologies shaping the future of this dynamic field.

Help employers find you! Check out all the jobs and post your resume.

Back to news